Medingo’s insulin patch approved; shares rocket
Medingo’s insulin dispensing patch has been approved by the US Food and Drug Administration (FDA), sending shares in its parent company soaring to a 12 month high.
Medingo’s insulin dispensing patch has been approved by the US Food and Drug Administration (FDA), sending shares in its parent company soaring to a 12 month high.
Shareholders have filed an $8bn (€5.7bn) lawsuit against Genzyme alleging that the company’s CEO “issued a series of materially false and misleading statements” about its manufacturing problems.
Despite some gains, demand for pre-clinical development services at Covance fell for the second quarter running, offsetting progress made by its late-stage trial and laboratory analysis businesses.
Good adherence pack sales and profits growth helped US packaging group MeadWestvaco to a positive set of Q2 financials, despite a 16 per cent drop in sales for the period.
In response to rising demand from the pharma industry NeuroScience Associates (NSA) is opening a new laboratory that will quadruple capacity for its brain and spinal cord histology services.